Cecilia Rus

497 total citations
12 papers, 378 citations indexed

About

Cecilia Rus is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Cecilia Rus has authored 12 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Cecilia Rus's work include Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer therapeutics and mechanisms (4 papers). Cecilia Rus is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer therapeutics and mechanisms (4 papers). Cecilia Rus collaborates with scholars based in Italy and United States. Cecilia Rus's co-authors include Mario Boccadoro, Antonio Palumbo, S Triolo, Alessandro Pileri, Alessandra Bertola, Luisa Giaccone, Paola Omedè, Patrizia Pregno, Eugenio Gallo and Sara Bringhen and has published in prestigious journals such as Blood, Clinical Chemistry and Leukemia & lymphoma.

In The Last Decade

Cecilia Rus

12 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cecilia Rus Italy	5	361	248	203	34	20	12	378
S Triolo Italy	7	347 1.0×	223 0.9×	198 1.0×	36 1.1×	25 1.3×	13	367
Evžen Gregora Czechia	11	253 0.7×	218 0.9×	130 0.6×	43 1.3×	14 0.7×	29	301
Marti McKinley United States	9	427 1.2×	395 1.6×	283 1.4×	35 1.0×	9 0.5×	17	507
Edvan de Queiroz Crusoé Brazil	8	229 0.6×	233 0.9×	156 0.8×	33 1.0×	16 0.8×	41	353
Dixil Francis United States	4	231 0.6×	197 0.8×	100 0.5×	32 0.9×	9 0.5×	5	279
Nola Kennedy Australia	5	267 0.7×	202 0.8×	181 0.9×	11 0.3×	31 1.6×	9	289
Ma Teresa Cibeira Spain	8	272 0.8×	224 0.9×	153 0.8×	51 1.5×	6 0.3×	13	306
Bart Barlogie United States	5	192 0.5×	215 0.9×	107 0.5×	63 1.9×	20 1.0×	9	290
Diane E. Durecki United States	6	320 0.9×	320 1.3×	170 0.8×	42 1.2×	8 0.4×	8	374
Joan Bladé Spain	7	242 0.7×	172 0.7×	113 0.6×	79 2.3×	13 0.7×	13	267

Countries citing papers authored by Cecilia Rus

Since Specialization

Citations

This map shows the geographic impact of Cecilia Rus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilia Rus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilia Rus more than expected).

Fields of papers citing papers by Cecilia Rus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecilia Rus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilia Rus. The network helps show where Cecilia Rus may publish in the future.

Co-authorship network of co-authors of Cecilia Rus

This figure shows the co-authorship network connecting the top 25 collaborators of Cecilia Rus. A scholar is included among the top collaborators of Cecilia Rus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecilia Rus. Cecilia Rus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Capello, Daniela, Michaela Cerri, Davide Rossi, et al.. (2009). Molecular pathology of post-transplant lymphoproliferative disorders. 1(5). 1 indexed citations

2.

Cavallo, Federica, Maria Teresa Ambrosini, Cecilia Rus, Mario Boccadoro, & Antonio Palumbo. (2007). The treatment of the elderly multiple myeloma patients. Leukemia & lymphoma. 48(3). 469–480. 2 indexed citations

3.

Palumbo, Antonio, Alessandra Larocca, Cecilia Rus, et al.. (2007). A Phase I/II Trial on Melphalan, Prednisone, Thalidomide and Defribotide Combination in Relapsed/Refractory Multiple Myeloma Patients.. Blood. 110(11). 2715–2715. 1 indexed citations

4.

Palumbo, Antonio, Ilaria Avonto, Benedetto Bruno, et al.. (2006). Intermediate-Dose Melphalan (100 mg/m2)/Bortezomib/Thalidomide/Dexamethasone and Stem Cell Support in Patients with Refractory or Relapsed Myeloma. Clinical Lymphoma & Myeloma. 6(6). 475–477. 19 indexed citations

5.

Palumbo, Antonio, Maria Teresa Ambrosini, Giulia Benevolo, et al.. (2006). Combination of Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) for Relapsed Multiple Myeloma: Results of a Phase I/II Clinical Trial.. Blood. 108(11). 407–407. 5 indexed citations

6.

Palumbo, Antonio, Cecilia Rus, Davide Rossi, et al.. (2006). A Multi-Center Phase I/II Study of Melphalan, Prednisone, Thalidomide and Defibrotide in Avanced Multiple Myeloma Patients.. Blood. 108(11). 3560–3560. 3 indexed citations

7.

Palumbo, Antonio, Sara Galimberti, Patrizia Falco, et al.. (2006). Time to First Progression, but Not Β2-Microglobulin, Predicts Outcome in Myeloma Patients Who Received Thalidomide as Salvage Therapy.. Blood. 108(11). 3562–3562. 1 indexed citations

8.

Montaruli, Barbara, et al.. (2005). Lupus Anticoagulant: Performance of a New, Fully Automated Commercial Screening and Confirmation Assay. Clinical Chemistry. 51(6). 1031–1033. 2 indexed citations

9.

Boccadoro, Mario, Antonio Palumbo, Sara Galimberti, et al.. (2002). Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.. PubMed. 87(8). 846–50. 62 indexed citations

10.

Palumbo, Antonio, Luisa Giaccone, Alessandra Bertola, et al.. (2001). Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma.. PubMed. 86(4). 399–403. 157 indexed citations

11.

Palumbo, Antonio, S Triolo, Sara Bringhen, et al.. (1999). Dose-Intensive Melphalan With Stem Cell Support (MEL100) Is Superior to Standard Treatment in Elderly Myeloma Patients. Blood. 94(4). 1248–1253. 4 indexed citations

12.

Palumbo, Antonio, S Triolo, Sara Bringhen, et al.. (1999). Dose-Intensive Melphalan With Stem Cell Support (MEL100) Is Superior to Standard Treatment in Elderly Myeloma Patients. Blood. 94(4). 1248–1253. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact